Creative Planning
ANGO icon

Creative Planning’s AngioDynamics ANGO Stock Holding History

Creative Planning’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-107
Closed -$980 – 3476
2024
Q4 		$980 Buy
+107
New +$787 ﹤0.01% 3520
2017
Q3 		– Sell
-12
Closed – – 1966
2017
Q2 		$0 Hold
12
– – ﹤0.01% 4596
2017
Q1 		$0 Hold
12
– – ﹤0.01% 4633
2016
Q4 		$0 Buy
+12
New +$200 ﹤0.01% 4605
2015
Q4 		– Sell
-158
Closed -$2K – 4393
2015
Q3 		$2K Buy
+158
New +$2.38K ﹤0.01% 3911
2013
Q3 		– Sell
-300
Closed -$3K – 3200
2013
Q2 		$3K Buy
+300
New +$3.19K ﹤0.01% 2690

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Creative Planning's ANGO Position: Q1 2025 in Review

Creative Planning sold out of AngioDynamics (ANGO) in Q1 2025, closing a stake of 107 shares — an estimated $980 sold.

Creative Planning first reported a position in ANGO in Q2 2013 and held it in 6 quarters. The position peaked at $3K in Q2 2013. 154 funds tracked by Wall St. Rank hold ANGO as of Q1 2025.

  • Creative Planning reported no remaining AngioDynamics position as of Q1 2025 after selling out during the quarter.
  • Creative Planning sold 107 AngioDynamics shares in Q1 2025, an estimated $980.
  • Creative Planning first reported a position in AngioDynamics in Q2 2013 and held it in 6 quarters.
  • Creative Planning's AngioDynamics position peaked at $3K in Q2 2013.
  • 154 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2025.

Based on Creative Planning's 13F filing for Q1 2025, filed 15 May 2025.